|
|
|
Volumn 6, Issue 2 SUPPL. 1, 2000, Pages 8-14
|
|
Mechanistic and clinical rationales for using β-blockers in heart failure
|
|
Author keywords
blockade; adrenergic receptors; Congestive heart failure; Pharmacotherapy
|
|
Indexed keywords
ANGIOTENSIN;
BETA ADRENERGIC RECEPTOR BLOCKING AGENT;
BISOPROLOL;
BUCINDOLOL;
CARVEDILOL;
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
METOPROLOL;
NORADRENALIN;
ARTICLE;
CARDIOVASCULAR EFFECT;
HEART FAILURE;
HEART LEFT VENTRICLE EJECTION FRACTION;
HEART LEFT VENTRICLE FUNCTION;
HEART VENTRICLE REMODELING;
HEMODYNAMICS;
HUMAN;
INOTROPISM;
PATHOPHYSIOLOGY;
PATIENT SELECTION;
PRIORITY JOURNAL;
ADRENERGIC BETA-ANTAGONISTS;
ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
CHRONIC DISEASE;
CLINICAL TRIALS;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DRUG ADMINISTRATION SCHEDULE;
HEART FAILURE, CONGESTIVE;
HUMANS;
PATIENT SELECTION;
RECEPTORS, ADRENERGIC, BETA-1;
RECEPTORS, ADRENERGIC, BETA-2;
VENTRICULAR DYSFUNCTION, LEFT;
VENTRICULAR REMODELING;
|
|
EID: 0033937122
PISSN: 10719164
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (50)
|
|
References (32)
|
